Korean J Helicobacter Up Gastrointest Res.
2019 Dec;19(4):231-235. 10.7704/kjhugr.2019.0013.
Management of Antithrombotics before Endoscopy and Biopsy
- Affiliations
-
- 1Division of Gastroenterology, Department of Internal Medicine, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Incheon, Korea. kijoons@catholic.ac.kr
- KMID: 2469314
- DOI: http://doi.org/10.7704/kjhugr.2019.0013
Abstract
- Antithrombotics are increasingly used for the management and prevention of cardiovascular diseases, and endoscopists often have to decide whether to continue or stop these medications before endoscopy. The development of novel antithrombotics, such as direct oral anticoagulants, has complicated their management before endoscopy. Although the discontinuation of anticoagulants may decrease the incidence of bleeding after endoscopic procedures, discontinuation may also lead to more serious cardiovascular complications. Although the majority of current practice guidelines recommend continuation of antithrombotics before elective endoscopy and biopsy, surveys have shown that many endoscopists do not adhere to these guidelines, probably due to legal aspirations from post endoscopic bleeding. Thus, we examined the current guidelines for the management of antithrombotics before endoscopy.
Keyword
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Management of Antithrombotic Therapy for Gastroenterological Endoscopy from a Cardio-Cerebrovascular Physician's Point of View
- Clinical Practice and Guidelines for Managing Antithrombotics before and after Endoscopy: A National Survey Study
- Management of Patients on Antithrombotic Agents Undergoing Endoscopy
- Management of Antithrombotics before Endoscopy-Balancing the Risks
- Advances in the Management of Upper Gastrointestinal Subepithelial Tumor: Pathologic Diagnosis Using Endoscopy without Endoscopic Ultrasound-Guided Biopsy
